Clinical Trials Directory

Trials / Unknown

UnknownNCT04817293

Prolonged Symptoms and Reasons for Consultation in Town Medicine Associated With COVID-19 Infection in the Hauts de France Region

Coordinated Research on Prolonged Symptoms and Reasons for Consultation in Town Medicine Associated With SARS-COV-2 Infection: a Transversal Study in Town in the Hauts de France Region

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Tourcoing Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Several publications document the occurrence of prolonged or late-onset symptoms beyond 3 weeks after the first clinical manifestations of SARS-COV2 infection. These manifestations may be related to thromboembolic or inflammatory events or other mechanisms that are not yet well understood. The psychosomatic origin secondary to psychiatric disorders prior to the infection or in reaction to it is also to be evoked. The identification of the clinical manifestations observed, and their clinical and paraclinical evolution are essential to better understand the natural evolution of COVID-19, to specify the physiopathological mechanisms and to identify potential avenues of management for the patients. In addition, the impact of COVID-19 infection on primary care visits is not known. In general practice, these patients benefit from explorations and even diagnoses that may explain the persistence of symptoms (autoimmune diseases, thrombosis, somatoform disorders, hyperventilation syndrome, etc.). The objective of the COCO\_Vi\_LATE project is to carry out a cross-sectional study of patients presenting persistent and/or recurrent symptoms after an infection with SARS-COV-2 who will be compared to individuals with a short form of infection with COVID-19

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaireQuestionnaire SSD-12 and EQ5D5L
OTHERmedical consultationMedical consultation during the visit with data collection

Timeline

Start date
2021-04-06
Primary completion
2022-10-01
Completion
2023-02-01
First posted
2021-03-26
Last updated
2022-05-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04817293. Inclusion in this directory is not an endorsement.